Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as - Melatonin - Active light ttherapy
Melatonin- Active light ttherapy · 1 trial · 1 indication
The Idiopathic Hypersomnia Severity Severity Scale is a self-administered questionnaire that was designed specifically to quantify HI symptoms the minimum value is 0 and the maximum values 50 means a worse outcome.
| Arm | Type | Description |
|---|---|---|
| Active therapy | EXPERIMENTAL | Active therapy combining evening melatonin + morning active light over 6 weeks |
| Placebo therapy | PLACEBO_COMPARATOR | placebo therapy combining evening melatonin placebo + morning placebo light over 6 weeks. |
| Name | Type | Description |
|---|---|---|
| - Melatonin - Active light ttherapy | COMBINATION_PRODUCT | 1 tablet per day, in the evening + morning light therapy over 6 weeks |
| - Placebo drug - Placebo light therapy | COMBINATION_PRODUCT | 1 tablet per day in the evening + morning placebo light therapy |
Inclusion criteria: * Male or female patient * Age ≥ 18 and ≤ 40 years at signature of informed consent form * Diagnosed with Idiopathic hypersomnia in a reference/competence center of hypersomnia rare disease network according to ICSD-3 criteria (International classification of sleep disorders) wi...